CENTOGENE Announces Commencement of Testing for COVID-19

CENTOGENE will commence testing for the novel coronavirus, or COVID-19. Testing for the virus is part of the Company’s initiative to help local, national and international authorities in their efforts to diagnose cases of COVID-19. Initially, the Company will provide testing for the Mecklenburg-Western Pomerania region and the Company expects to expand testing activities to additional geographical areas within the upcoming weeks.

"In the midst of the COVID-19 pandemic, CENTOGENE is maintaining its commitment to our patients, employees and the global community. This means using our advanced technical equipment and broad expert medical knowledge to support our communities to prevent a further spread of the virus and help individuals who may not otherwise have access to testing," Prof. Dr. Arndt Rolfs, CEO of the Company, said.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.